These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
284 related articles for article (PubMed ID: 27087513)
1. Adipocytokines in Cardiovascular and Metabolic Diseases. Ouchi N J Atheroscler Thromb; 2016 Jun; 23(6):645-54. PubMed ID: 27087513 [TBL] [Abstract][Full Text] [Related]
2. Adipocytokines and obesity-linked disorders. Ouchi N; Ohashi K; Shibata R; Murohara T Nagoya J Med Sci; 2012 Feb; 74(1-2):19-30. PubMed ID: 22515108 [TBL] [Abstract][Full Text] [Related]
3. Cardiovascular risk of adipokines: a review. Dutheil F; Gordon BA; Naughton G; Crendal E; Courteix D; Chaplais E; Thivel D; Lac G; Benson AC J Int Med Res; 2018 Jun; 46(6):2082-2095. PubMed ID: 28974138 [TBL] [Abstract][Full Text] [Related]
4. Visceral fat and insulin resistance - what we know? Janochova K; Haluzik M; Buzga M Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2019 Feb; 163(1):19-27. PubMed ID: 30398218 [TBL] [Abstract][Full Text] [Related]
5. Protective Roles of Adipocytokines and Myokines in Cardiovascular Disease. Ouchi N; Ohashi K; Shibata R; Murohara T Circ J; 2016 Sep; 80(10):2073-80. PubMed ID: 27581346 [TBL] [Abstract][Full Text] [Related]
6. Obesity-Induced Changes in Adipose Tissue Microenvironment and Their Impact on Cardiovascular Disease. Fuster JJ; Ouchi N; Gokce N; Walsh K Circ Res; 2016 May; 118(11):1786-807. PubMed ID: 27230642 [TBL] [Abstract][Full Text] [Related]
7. Adipokines at the crossroad between obesity and cardiovascular disease. Molica F; Morel S; Kwak BR; Rohner-Jeanrenaud F; Steffens S Thromb Haemost; 2015 Mar; 113(3):553-66. PubMed ID: 25338625 [TBL] [Abstract][Full Text] [Related]
8. [The role of adipokines in formation of lipid and carbohydrate metabolic disorders in patients with cardiovascular disease]. Kravchun P; Kadykova O; Gabisoniia T Georgian Med News; 2012 Dec; (213):26-31. PubMed ID: 23293229 [TBL] [Abstract][Full Text] [Related]
9. Adipocytokines in obesity and metabolic disease. Cao H J Endocrinol; 2014 Feb; 220(2):T47-59. PubMed ID: 24403378 [TBL] [Abstract][Full Text] [Related]
10. The role of adipokines in cardiovascular disease. Shibata R; Ouchi N; Ohashi K; Murohara T J Cardiol; 2017 Oct; 70(4):329-334. PubMed ID: 28325521 [TBL] [Abstract][Full Text] [Related]
11. Relevance of Leptin and Other Adipokines in Obesity-Associated Cardiovascular Risk. Landecho MF; Tuero C; Valentí V; Bilbao I; de la Higuera M; Frühbeck G Nutrients; 2019 Nov; 11(11):. PubMed ID: 31694146 [TBL] [Abstract][Full Text] [Related]
12. The role of fat topology in the risk of disease. Matsuzawa Y Int J Obes (Lond); 2008 Dec; 32 Suppl 7():S83-92. PubMed ID: 19136997 [TBL] [Abstract][Full Text] [Related]
13. Adipocytokines and the metabolic complications of obesity. Rasouli N; Kern PA J Clin Endocrinol Metab; 2008 Nov; 93(11 Suppl 1):S64-73. PubMed ID: 18987272 [TBL] [Abstract][Full Text] [Related]
14. Adiponectin and hypertension. Ohashi K; Ouchi N; Matsuzawa Y Am J Hypertens; 2011 Mar; 24(3):263-9. PubMed ID: 20930707 [TBL] [Abstract][Full Text] [Related]
15. Therapy Insight: adipocytokines in metabolic syndrome and related cardiovascular disease. Matsuzawa Y Nat Clin Pract Cardiovasc Med; 2006 Jan; 3(1):35-42. PubMed ID: 16391616 [TBL] [Abstract][Full Text] [Related]
16. The concept of metabolic syndrome: contribution of visceral fat accumulation and its molecular mechanism. Matsuzawa Y; Funahashi T; Nakamura T J Atheroscler Thromb; 2011; 18(8):629-39. PubMed ID: 21737960 [TBL] [Abstract][Full Text] [Related]
17. The potential of adipokines as therapeutic agents for cardiovascular disease. Shibata R; Ohashi K; Murohara T; Ouchi N Cytokine Growth Factor Rev; 2014 Aug; 25(4):483-7. PubMed ID: 25066649 [TBL] [Abstract][Full Text] [Related]
18. The Role of Adipocytokines in Coronary Atherosclerosis. Liberale L; Bonaventura A; Vecchiè A; Casula M; Dallegri F; Montecucco F; Carbone F Curr Atheroscler Rep; 2017 Feb; 19(2):10. PubMed ID: 28185154 [TBL] [Abstract][Full Text] [Related]
19. Adiponectin: a key player in obesity related disorders. Matsuzawa Y Curr Pharm Des; 2010 Jun; 16(17):1896-901. PubMed ID: 20370675 [TBL] [Abstract][Full Text] [Related]
20. Adipocytokines in relation to cardiovascular disease. Van de Voorde J; Pauwels B; Boydens C; Decaluwé K Metabolism; 2013 Nov; 62(11):1513-21. PubMed ID: 23866981 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]